2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2005020159v1 16/6/1733    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, D. Articles by Floege, J. Search for Related Content PubMed PubMed Citation Articles by Yu, D. Articles by Floege, J.

Urinary Podocyte Loss Is a More Specific Marker of Ongoing Glomerular Damage than Proteinuria

Donghai Yu^*,, Arndt Petermann^*, Uta Kunter^*, Song Rong^*,, Stuart J. Shankland and Juergen Floege^*

^* Department of Medicine, Division of Nephrology and Clinical Immunology, University of Aachen, Germany; Tongji Medical College, HuaZhong University of Science and Technology; Wuhan; China; Department of Medicine, Division of Nephrology, University of Washington School of Medicine, Seattle, Washington

Address correspondence to: Dr. Arndt Petermann, Division of Nephrology and Clinical Immunology, RWTH Aachen, Pauwelstrasse 30, Aachen NRW 52057, Germany. Phone: +49-0-241-8089-531; Fax: +49-0-241-8082-446; E-mail: apetermann{at}ukaachen.de

Received for publication February 11, 2005. Accepted for publication March 4, 2005.

Podocyte loss contributes to the development of glomerulosclerosis. Although podocyte detachment has been recognized as a new mechanism of podocyte loss in glomerular diseases, its time course and relationship to disease activity are not known. Urinary excretion of viable podocytes was quantified in two models of transient glomerular injury, i.e., rats with puromycin aminonucleoside-induced nephrosis (PAN) and mesangioproliferative nephropathy (anti-Thy 1.1 nephritis model), as well as in a model of continuous glomerular injury, i.e., hypertensive nephropathy (5/6-nephrectomy model), and in aging rats. The number of glomerular Wilm’s tumor (WT)-1–positive podocytes and the glomerular expression of cell-cycle proteins in vivo were assessed. Urinary podocyte loss occurred in both primary (PAN) and secondary (anti-Thy 1.1 nephritis) in parallel to the onset of proteinuria. However, subsequently proteinuria persisted despite remission of podocyturia. In continuous glomerular injury, i.e., after 5/6-nephrectomy, podocyturia paralleled the course of proteinuria and of systemic hypertension, whereas no podocyturia became detectable during normal aging (up to 12 mo). Despite podocyte detachment of varying degrees, no decrease in glomerular podocyte counts (i.e., WT-1 positive nuclei) was noted in either disease model. Podocyturia in the PAN and anti-Thy 1.1 nephritis model was preceded by entry of glomerular podocytes into the cell cycle, i.e., cyclin D1, cdc2, and/or proliferating cell nuclear antigen (PCNA) expression. Podocyturia is a widespread phenomenon in glomerular disease and not simply a reflection of proteinuria because it is limited to phases of ongoing glomerular injury. The data suggest that podocyturia may become a more sensitive means to assess the activity of glomerular damage than proteinuria.

This article has been cited by other articles:

				J. Achenbach, M. Mengel, I. Tossidou, I. Peters, J.-K. Park, M. Haubitz, J. H. Ehrich, H. Haller, and M. Schiffer Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3138 - 3145. [Abstract] [Full Text] [PDF]

				G. Wang, F. M.-M. Lai, K.-B. Lai, K.-M. Chow, B. C.-H. Kwan, P. K.-T. Li, and C.-C. Szeto Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker Eur. J. Endocrinol., March 1, 2008; 158(3): 317 - 322. [Abstract] [Full Text] [PDF]

				M. Toyoda, B. Najafian, Y. Kim, M. L. Caramori, and M. Mauer Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy Diabetes, August 1, 2007; 56(8): 2155 - 2160. [Abstract] [Full Text] [PDF]

				M. Hara, T. Yanagihara, and I. Kihara Cumulative Excretion of Urinary Podocytes Reflects Disease Progression in IgA Nephropathy and Schonlein-Henoch Purpura Nephritis Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 231 - 238. [Abstract] [Full Text] [PDF]

				M. Barton, J. J. Mullins, M. A. Bailey, and M. Kretzler Role of Endothelin Receptors for Renal Protection and Survival in Hypertension: Waiting for Clinical Trials Hypertension, November 1, 2006; 48(5): 834 - 837. [Full Text] [PDF]

				G. Colucci, J. Floege, and F. P. Schena The urinary sediment beyond light microscopical examination. Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1482 - 1485. [Full Text] [PDF]

				A. Hartner, L. Schaefer, M. Porst, N. Cordasic, A. Gabriel, B. Klanke, D. P. Reinhardt, and K. F. Hilgers Role of fibrillin-1 in hypertensive and diabetic glomerular disease Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1329 - F1336. [Abstract] [Full Text] [PDF]

				M. Kretzler Role of Podocytes in Focal Sclerosis: Defining the Point of No Return J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2830 - 2832. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673